Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million (BusinessWire)

Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million

UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts valued at $135.4 million. The first is for the development of a medical countermeasure, and the second is to support the development of a new technology platform. Ology Bioservices is a graduate of UF Innovate | Sid Martin Biotech.

Medical Countermeasure Award: The PRISM Office awarded Ology Bioservices a $130.3 million, 10-year contract, entitled, “Development and Utilization of a Monoclonal Antibody Platform Prototype for Development of Monoclonal Antibodies as Medical Countermeasures Against Threats of Interest.” This program is part of PRISM’s Advanced Development and Manufacturing of Antibody Technologies (ADAMANT) platform concept, which is intended to explore how monoclonal antibodies can be used as next-generation medical countermeasures against chemical and biological threats.

Learn more about Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million.
X